ONCO · Onconetix Inc
United States · RS rating 18 · As of 2026-11-03
| Price | 0.57 USD |
|---|---|
| 1-day change | +4.8% |
| RS rating (overall / 1M / 3M / 12M) | 18 / 27 / 12 / 3 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 25 / 12 / 53 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +98.1% |
| Sales growth Q/Q | -0.0% |
| Distance from 52-week high | +96.4% |
| Market cap (USD) | $461,766 |